Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
84 hedge funds and large institutions have $64.1M invested in Enzo Biochem, Inc. in 2020 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 21 reducing their positions, and 6 closing their positions.
133% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 6
38% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 21
11% more funds holding
Funds holding: 76 → 84 (+8)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
12% less capital invested
Capital invested by funds: $73M → $64.1M (-$8.96M)
52% less call options, than puts
Call options by funds: $113K | Put options by funds: $234K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RAM
Roumell Asset Management
Chevy Chase,
Maryland
|
+$1.57M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$934K |
| 3 |
Los Angeles Capital Management
Los Angeles,
California
|
+$621K |
| 4 |
Renaissance Technologies
New York
|
+$394K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$330K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EGA
Evermore Global Advisors
Summit,
New Jersey
|
-$2.03M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.59M |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
-$542K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$310K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$275K |
ENZ Hedge Fund Activity: Q2 2020 in Review
84 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q2 2020, worth a combined $64.1M — down 12% from $73M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ENZ positions and 6 closed out — a net gain of 8 holders — while 29 added to existing stakes and 21 trimmed.
The largest buyer was Roumell Asset Management, opening a new position worth an estimated $1.57M. The largest seller was Evermore Global Advisors, cutting an estimated $2.03M.
- 84 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q2 2020, up from 76 in Q1 2020.
- Funds reported $64.1M of Enzo Biochem, Inc. stock for Q2 2020, down 12% quarter-over-quarter.
- 14 funds opened new Enzo Biochem, Inc. positions in Q2 2020 and 6 closed out, a net change of +8 holders.
- The largest Enzo Biochem, Inc. buyer in Q2 2020 was Roumell Asset Management, an estimated $1.57M added.
- The largest Enzo Biochem, Inc. seller in Q2 2020 was Evermore Global Advisors, an estimated $2.03M sold.
Based on aggregated 13F filings for Q2 2020.